Fatigue Correlates With Disability in Patients With Relapsing-Remitting MS
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
MONDAY, Aug. 14, 2023 -- A lower disability rate, better physical condition, and higher daily-living activity predict lower fatigue levels in patients with relapsing-remitting multiple sclerosis (RRMS), according to a study published online July 21 in Multiple Sclerosis and Related Disorders.
Marko Luostarinen, from University of Eastern Finland in Kuopio, and colleagues examined the association between patients' disability, fatigue, and accelerometer-measured physical activity. The analysis included data from 41 patients with RRMS and 20 healthy controls.
The researchers found that patients with an Expanded Disability Status Scale (EDSS) level of 0 to 2.5 had higher fatigue levels than healthy controls but lower levels than patients with an EDSS level of 3 to 5.5. There was a significant correlation seen between fatigue and disability level. A similar correlation was observed with the MS Functional Composite (MSFC) test in the patient group. While there was no correlation seen between daily activity and the EDSS or the MSFC, total daily activity correlated with fatigue as measured by the Fatigue Severity Scale.
"A suitable form of exercise should be found for MS patients, considering their functional capacity, to maintain their ability to function as well as possibly reduce their incidence of fatigue," the authors write. "This research is unique because it was extensive and used modern methods. Furthermore, more specific research is required into patients' disability and actual physical activity levels, taking the existing levels of patients’ disability into account."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2023
Read this next
High-Efficacy Therapy Cuts Disability Progression in Pediatric MS
FRIDAY, April 12, 2024 -- Treatment of pediatric-onset relapsing-remitting multiple sclerosis with high-efficacy therapy reduces the risk for transition across disability states...
AAN: Monoclonal Antibodies for MS During Breastfeeding Not Harmful
TUESDAY, March 12, 2024 -- For mothers with multiple sclerosis or neuromyelitis optica spectrum disease, receipt of monoclonal antibodies (mAb) during breastfeeding is not...
Frexalimab Has Favorable Effect on Relapsing Multiple Sclerosis
WEDNESDAY, Feb. 14, 2024 -- For patients with relapsing multiple sclerosis, the anti-CD40L monoclonal antibody frexalimab has a favorable effect on the number of new...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.